Swati Gupta leads integration of the IAVI research and development portfolio and the organization’s global network of laboratories. She is leveraging IAVI’s platforms and expertise to expand product development efforts beyond HIV, including in emerging infectious disease.
Previously, she was Executive Director with Merck Vaccines, where she worked on the development of innovative partnership models to address cross-cutting issues related to vaccine science and technology.
From 2000 to 2014, Gupta was in the Department of Epidemiology at Merck Research Laboratories where she led international, cohort studies in support of vaccine and infectious disease products in development, including research on diseases such as HIV, HPV, influenza, dengue, and C.difficile. From 1998 to 2000, Gupta worked as a scientist in HIV Surveillance at the Communicable Disease Surveillance Centre in the UK.
Gupta holds a doctorate in epidemiology from Johns Hopkins School of Public Health and a MPH in epidemiology from Yale University.